Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 241

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 9
Chunk 241
---
 diluted basis. Information on that transaction is set forth in this Annual Report under “ Item 4. Information
on the Company - B. Business Overview - Market Segments - Human Health - Biomica Ltd. - Overview” and is
incorporated by reference herein.

101

2023 Registered Direct Offering

On July 17, 2023, we entered into a Securities Purchase Agreement,
with certain institutional investors, pursuant to which we issued and sold to such investors in a registered direct offering 850,000 ordinary
shares, at a purchase price of $10.00 per share. The total gross proceeds to our company from the 2023 Offering was $8,500,000. Information
on that transaction is set forth in this Annual Report under “ Item 5. Operating and Financial Review and Prospects - B. Liquidity
and Capital Resources - Public Offerings of Ordinary Shares - 2023 Registered Direct Offering” and is incorporated by reference
herein.

We also entered into a letter agreement, or the Placement Agency
Agreement, with AGP, as sole placement agent, dated July 17, 2023, pursuant to which the Placement Agent agreed to serve as our placement
agent in connection with the Offering. We paid AGP a cash placement fee equal to 7.0% of the gross proceeds received for the ordinary
shares sold in the 2024 Offering.

Casterra Agreements with ENI and its Affiliate

On November 14, 2022, our subsidiary, Casterra, entered into an
agreement with an affiliate of ENI, whereby Casterra will provide its unique castor varieties and its broad know-how in cultivation of
castor at a commercial scale for biofuel production. Under the framework of the agreement, the initial focus is the purchase agreement
of castor seed varieties from Casterra for growing castor in specific African territories and the provision of technical support. The
agreement also allows for the potential for long-term cooperation in castor cultivation between this customer and Casterra, with the potential
for expansion into additional territories on the African continent. In November 2023, the agreement was extended until November 1, 2024.

On June 21, 2023, Casterra announced that it entered into a framework
agreement to sell seeds of its proprietary castor varieties to ENI Kenya B. V., or ENI, for cultivation in specific African territories
at a commercial scale for biofuel production. Pursuant to this